Customer Support: 800-526-4902
 

Christopher J. McDonald: Lawyer with Labaton Sucharow LLP

Christopher J. McDonald

LinkedIn
Partner
New York,  NY  U.S.A.
Phone212-907-0861

Peer Rating
N/R
 N/R

Client Rating

Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials
 

Practice Areas

  • Antitrust Litigation
  • Securities Litigation
 
University Manhattan College, B.A., cum laude, 1985
 
Law SchoolFordham University School of Law, J.D., 1992
 
Admitted1993, New York; U.S. District Court: 1994, Southern District of New York, 1994, Eastern District of New York, 1998, Western District of Michigan; U.S. Court of Appeals: 2005, Third Circuit, 2006, Second Circuit, 2009, Ninth Circuit
 
BornNew York, N.Y., June 11, 1963
 
Biography

Christopher J. McDonald, a member of the Firm's Antitrust Practice Group, represents businesses, associations and individuals injured by anticompetitive activities. Mr. McDonald's practice also involves prosecuting complex securities fraud cases on behalf of institutional investors.

In the antitrust field, Mr. McDonald represented end-payors (e.g., union health and welfare funds and consumers) of the prescription drug TriCor® in the In re TriCor Indirect Purchaser Antitrust Litigation, where he obtained a $65.7 million settlement on behalf of plaintiffs and the class.

In the securities field, Mr. McDonald is currently prosecuting In re Schering-Plough Corporation/ENHANCE Securities Litigation to recover losses investors suffered after the disclosure of negative clinical trial data for Vytorin®, a fixed-dose combination pill comprised of ezitimibe (Schering-Plough's Zetia®) and simvastatin (Merck & Co., Inc.'s Zocor®). He was also part of the team that litigated In re Bristol-Myers Squibb Securities Litigation, where Labaton Sucharow was able to secure a $185 million settlement and meaningful corporate governance reforms on behalf of Bristol-Myers Squibb shareholders following negative disclosures about omapatrilat, an experimental hypertension drug. The settlement with BMS is the largest ever obtained against a pharmaceutical company in a securities fraud case that did not involve a restatement of financial results.

A litigator for most of his career, Mr. McDonald also has in-house and regulatory experience. As a senior attorney with a telecommunications company he regularly addressed legal, economic and public policy issues before state public utility commissions.

During his time at Fordham University School of Law, Mr. McDonald was on the Law Review.

Mr. McDonald is a member of the New York State Bar Association and the Association of the Bar of the City of New York.

Noteworthy

The National Law Journal's 2009 Plaintiffs' Hot List

Ongoing Cases

In re Schering-Plough Corporation / ENHANCE Securities Litigation

In re Amgen Inc. Securities Litigation

Settled Cases

In re Beckman Coulter, Inc. Securities Litigation

In re TriCor Indirect Purchaser Antitrust Litigation

In re Bristol-Myers Squibb Securities Litigation

In re Stock Exchange Options Trading Antitrust Litigation

In re Natural Gas Commodity Litigation

 
ISLN900834743
 
Profile Visibility
#4,672 in weekly profile views out of 90,234 lawyers in New York, New York
#62,278 in weekly profile views out of 1,447,639 total lawyers Overall

Office Information

Christopher J. McDonald
Labaton Sucharow LLP
140 Broadway
New York, NY 10005




Loading...
 

Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now